|
Post by joeypotsandpans on Aug 8, 2023 12:51:51 GMT -5
With the gap on the daily and hourly charts we can see this go down to $4.60 area on any pullbacks, would be a great buying area if looking to add or start a position IMO. This could happen on a bigger overall market correction which is certainly plausible coming towards the back half of Q3 and start of Q4. Having said that, I am expecting increasing coverage and upgrades going forward. 😉👍🏻
|
|
|
Post by awesomo on Aug 8, 2023 12:56:49 GMT -5
We did, when Afrezza surprisingly got FDA approval. Or maybe even when we got pumped and dumped to $6 back in 2017. Neither went too well afterwards though. I'll take these good earnings calls and a steady decline in short interest over that. SHORTly after Afrezza got FDA approval due to a unanimous recommendation of an Advisory Committee, MannKind inked a $1B+ worldwide marketing agreement. Yes, Sanofi fired their CEO and hired Oliver Brandicoot who was the lead executive that presided over the Pfizer disaster known as Exubera RAA and the "bong" which led immediately to a predictable jettison of MNKD from the Sanofi portfolio.
I would say that not only did the shorts not exit, they thrived which is how MNKD ended up on the SEC's SHO list of companies suffering from predatory naked shorting. That's such a great list. It's the SEC telling investors, "Hey, if I were you, I'd stay away from these stocks because the shorts are trying to kill them". A nice way to pile on to what the shorts started with "catch and kill".
If some shorts got burned by the 2017 price action, that would be lamentable, if you're a short.
I noticed the FINRA data for yesterday indicated more than 60% of the FINRA-reported volume (which is typically half what NASDAQ reports) was shares sold short. I'm betting today's percentage will be similar or higher.
Just once, I'd like to see an exceedingly disorderly exit of the shorts.
They initially got squeezed because the PPS jumped dramatically. Go ahead and check that spike right around July 2014. They then piled back on because of the Sanofi deal details and then later with the deal falling apart. Thanks for proving my point that disorderly exits don't always go so well because they are likely to pile back in with any sort of negativity.
|
|
|
Post by ktim on Aug 8, 2023 13:20:07 GMT -5
Was busy and didn't get to check market until just now. That's the pop I was thinking would occur after hours. Hard to predict where we'll be heading next few months, other than I will predict quite a bit higher than this before next earnings hit... whether up slowly the whole time, or sidewise and then a strong pre earnings runup. I think we'll have strong expectations for next quarter.
|
|
|
Post by ktim on Aug 8, 2023 13:24:19 GMT -5
Agree. Regardless of when and how shorts exit, you can take it to the bank that many are either concerned or rethinking their position after this 2Q report. Other than any of the short interest that is linked to convertible debt, which could be significant portion of it. They have no reason for concern and likely wouldn't cover until they get their shares from MNKD.
|
|
|
Post by dh4mizzou on Aug 8, 2023 13:25:21 GMT -5
So it seems someone decided the number today is $ 5.45.
|
|
|
Post by boytroy88 on Aug 8, 2023 13:51:44 GMT -5
So it seems someone decided the number today is $ 5.45. Dropped to 5.40
|
|
|
Post by peppy on Aug 8, 2023 14:04:22 GMT -5
Weehaw, we need $5.75 for the triangle break, then the fun begins.
The target is $12.
|
|
|
Post by prcgorman2 on Aug 8, 2023 14:05:37 GMT -5
It would be nice if the shorts could run out of rope.
|
|
|
Post by peppy on Aug 8, 2023 14:09:48 GMT -5
|
|
|
Post by mango on Aug 8, 2023 14:42:56 GMT -5
If it were not for Michael Castagna taking a huge risk and developing Tyvaso DPI and putting it through Phase 1 and inking the deal with UT because of the fantastic results, we wouldn’t be bringing in the $ we are seeing and we’d likely be hovering around $1 or even lower.
Thanks Mike! Let’s get some more products on market!
|
|
|
Post by Clement on Aug 8, 2023 15:02:36 GMT -5
So it seems someone decided the number today is $ 5.45. You nailed it.
|
|
|
Post by Clement on Aug 8, 2023 15:10:18 GMT -5
For the day, up 18% on 6X average volume!
|
|
|
Post by cretin11 on Aug 8, 2023 15:14:04 GMT -5
Short squeezes are hard to do anything with, by the time you figure out it truly is a short squeeze and not a deserved run up, it is over and the price comes back down to earth. FOMO prevented me from selling during the last squeeze. This time I will hopefully be smarter and at least sell covered calls. I did sell some Nov $8 calls this morning. We shall see where we go from here. Today was great for selling calls. Or at least it seems that way, but time will tell. It was most definitely a wonderful day for buying back puts.
|
|
|
Post by peppy on Aug 8, 2023 17:26:02 GMT -5
MNKD Nasdaq real time volume, Volume: 16,218,997 shares.
$5.45 18.48% +0.85
MNKD over $5.00, over $5.73 tomorrow, new 52 week high. MNKD will show up on the new highs lists over $5.00.
The target will be 12 over $5.75.
Some people will have their shares called apparently. weehaw.
|
|
|
Post by mymann on Aug 8, 2023 17:54:41 GMT -5
Only negative comment I can make is, where is that $12 sp Peppy keeps showing us in the charts? After that,I ll quit being a Debbie downer.
|
|